{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:18:05Z","timestamp":1791011885942,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,11,7]],"date-time":"2009-11-07T00:00:00Z","timestamp":1257552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00467-009-1337-0","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T07:00:38Z","timestamp":1257490838000},"page":"769-778","source":"Crossref","is-referenced-by-count":58,"title":["Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD)"],"prefix":"10.1007","volume":"25","author":[{"given":"Keith A.","family":"Hruska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Keefe","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,7]]},"reference":[{"key":"1337_CR1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945\u20131953","journal-title":"Kidney Int"},{"key":"1337_CR2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.ASN.0000113243.24155.2F","volume":"15","author":"LA Stevens","year":"2004","unstructured":"Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A (2004) Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 15:770\u2013779","journal-title":"J Am Soc Nephrol"},{"key":"1337_CR3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607\u2013617","journal-title":"Am J Kidney Dis"},{"key":"1337_CR4","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1681\/ASN.2004100835","volume":"16","author":"MR Davies","year":"2005","unstructured":"Davies MR, Lund RJ, Mathew S, Hruska KA (2005) Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol 16:917\u2013928","journal-title":"J Am Soc Nephrol"},{"key":"1337_CR5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000109671.99498.08","volume":"15","author":"RJ Lund","year":"2004","unstructured":"Lund RJ, Davies MR, Brown AJ, Hruska KA (2004) Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model. J Am Soc Nephrol 15:359\u2013369","journal-title":"J Am Soc Nephrol"},{"key":"1337_CR6","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112\u2013S119","journal-title":"Am J Kidney Dis"},{"key":"1337_CR7","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.2004040275","volume":"16","author":"Y Slinin","year":"2005","unstructured":"Slinin Y, Foley RN, Collins AJ (2005) Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16:1788\u20131793","journal-title":"J Am Soc Nephrol"},{"key":"1337_CR8","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","volume":"352","author":"MG Shlipak","year":"2005","unstructured":"Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C (2005) Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352:2049\u20132060","journal-title":"New Engl J Med"},{"key":"1337_CR9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1681\/ASN.2008020141","volume":"20","author":"RN Foley","year":"2009","unstructured":"Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA (2009) Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20:397\u2013404","journal-title":"J Am Soc Nephrol"},{"key":"1337_CR10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ki.1990.187","volume":"38","author":"HH Malluche","year":"1990","unstructured":"Malluche HH, Faugere MC (1990) Renal bone disease 1990: challenge for nephrologists. Kidney Int 38:193\u2013211","journal-title":"Kidney Int"},{"key":"1337_CR11","author":"J Bacchetta","year":"2009","unstructured":"Bacchetta J, Boutroy S, Vilayphiou N, Juillard L, Guebre-Egziabher F, Rognant N, Sornay-Rendu E, Szulc P, Laville M, Delmas PD, Fouque D, Chapurlat R (2009) Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II\u2013IV chronic kidney disease. J Bone Miner Res. doi: 0.1359\/jbmr.090831","journal-title":"J Bone Miner Res"},{"key":"1337_CR12","author":"RC Pereira","year":"2009","unstructured":"Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K (2009) Patterns of FGF-23, DMP1 and MEPE expression in patients with chronic kidney disease. Bone. doi: 10.1016\/j.bone.2009.08.008","journal-title":"Bone"},{"key":"1337_CR13","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1681\/ASN.2007121312","volume":"20","author":"T Kokubo","year":"2009","unstructured":"Kokubo T, Ishikawa N, Uchida H, Chasnoff SE, Xie X, Mathew S, Hruska KA, Choi ET (2009) CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas. J Am Soc Nephrol 20:1236\u20131245","journal-title":"J Am Soc Nephrol"},{"key":"1337_CR14","unstructured":"Fang Y, Zhang Y, Mathew S, Futhey J, Lund RJ, Hruska KA (2009) Early chronic kidney disease (CKD) stimulates vascular calcification (VD) and decreased bone formation rates prior to positive phosphate balance (abstract). J Am Soc Nephrol 20:36 A (abstract TH - FC 153)"},{"key":"1337_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/ajpendo.00016.2003","volume":"285","author":"LD Quarles","year":"2003","unstructured":"Quarles LD (2003) FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285:1\u20139","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1337_CR16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T (2004) Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561\u2013568","journal-title":"J Clin Invest"},{"key":"1337_CR17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456\u2013469","journal-title":"Cell"},{"key":"1337_CR18","unstructured":"Hruska KA, Mathew S (2008) The chronic kidney disease mineral bone disorder (CKD-MBD). In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Am Soc Bone Miner Res, Washington D.C, pp 343\u2013349"},{"key":"1337_CR19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","volume":"425","author":"LM Calvi","year":"2003","unstructured":"Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841\u2013846","journal-title":"Nature"},{"key":"1337_CR20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nature02041","volume":"425","author":"J Zhang","year":"2003","unstructured":"Zhang J, Niu C, Ye L, Huang H, He XI, Tong W-G, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L (2003) Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425:836\u2013841","journal-title":"Nature"},{"key":"1337_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ki.1976.42","volume":"9","author":"HH Malluche","year":"1976","unstructured":"Malluche HH, Ritz E, Lange HP (1976) Bone histology in incipient and advanced renal failure. Kidney Int 9:355\u2013362","journal-title":"Kidney Int"},{"key":"1337_CR22","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","volume":"64","author":"T Larsson","year":"2003","unstructured":"Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64:2272\u20132279","journal-title":"Kidney Int"},{"key":"1337_CR23","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","volume":"22","author":"L Craver","year":"2007","unstructured":"Craver L, Marco MP, Martinez I, Rue M, Borras M, Martin ML, Sarro F, Valdivielso JM, Fernandez E (2007) Mineral metabolism parameters throughout chronic kidney disease stages 1\u20135\u2013achievement of K\/DOQI target ranges. Nephrol Dial Transplant 22:1171\u20131176","journal-title":"Nephrol Dial Transplant"},{"key":"1337_CR24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2006","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL (2006) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int 71:31\u201338","journal-title":"Kidney Int"},{"key":"1337_CR25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI117718","volume":"95","author":"L Liaw","year":"1995","unstructured":"Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM (1995) The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of \u03b1v\u03b23 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 95:713\u2013724","journal-title":"J Clin Invest"},{"key":"1337_CR26","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1046\/j.1523-1755.2002.00625.x","volume":"62","author":"NX Chen","year":"2002","unstructured":"Chen NX, O\u2019Neill KD, Duan D, Moe SM (2002) Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 62:1724\u20131731","journal-title":"Kidney Int"},{"key":"1337_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.atherosclerosis.2007.11.031","volume":"199","author":"X Li","year":"2008","unstructured":"Li X, Yang HY, Giachelli CM (2008) BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199:271\u2013277","journal-title":"Atherosclerosis"},{"key":"1337_CR28","doi-asserted-by":"crossref","unstructured":"The ADHR consortium (Group 1: White KE, Evans WE, O\u2019Riordan JLH, Speer MC, Econs JJ, Groups 2: Lorenz-Depiereux B, Grabowski M, Meitinger T, Strom TM) (2000) Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 26:345\u2013348","DOI":"10.1038\/81664"},{"key":"1337_CR29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","volume":"86","author":"KE White","year":"2001","unstructured":"White KE, Jonsson KB, Carn G, Hampson G, Spector TD, Mannstadt M, Lorenz-Depiereux B, Miyauchi A, Yang IM, Ljunggren O, Meitinger T, Strom TM, Juppner H, Econs MJ (2001) The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86:497\u2013500","journal-title":"J Clin Endocrinol Metab"},{"key":"1337_CR30","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","volume":"143","author":"T Shimada","year":"2002","unstructured":"Shimada T, Muto T, Urakawa I, Yoneya T, Yamazaki Y, Okawa K, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2002) Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143:3179\u20133182","journal-title":"Endocrinology"},{"key":"1337_CR31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.ki.5002287","volume":"74","author":"WG Goodman","year":"2007","unstructured":"Goodman WG, Quarles LD (2007) Development and progression of secondary hyperparathyroidism in chronic kidney disease: Lessons from molecular genetics. Kidney Int 74:276\u2013288","journal-title":"Kidney Int"},{"key":"1337_CR32","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI114931","volume":"86","author":"T Naveh-Many","year":"1990","unstructured":"Naveh-Many T, Marx R, Keshet E, Pike JW, Silver J (1990) Regulation of 1, 25-dihydroxyvitamin D3 receptor gene expression by 1, 25-dihydroxyvitamin D3 in the parathyroid in vivo. J Clin Invest 86:1968\u20131975","journal-title":"J Clin Invest"},{"key":"1337_CR33","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1073\/pnas.82.12.4270","volume":"82","author":"J Silver","year":"1985","unstructured":"Silver J, Russell J, Sherwood LM (1985) Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 82:4270\u20134273","journal-title":"Proc Natl Acad Sci USA"},{"key":"1337_CR34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/jpet.106.101261","volume":"318","author":"JR Wu-Wong","year":"2006","unstructured":"Wu-Wong JR, Noonan W, Ma J, Dixon D, Nakane M, Bolin AL, Koch KA, Postl S, Morgan SJ, Reinhart GA (2006) Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther 318:90\u201398","journal-title":"J Pharmacol Exp Ther"},{"key":"1337_CR35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.ki.5002406","volume":"72","author":"M Mizobuchi","year":"2007","unstructured":"Mizobuchi M, Finch JL, Martin DR, Slatopolsky E (2007) Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int 72:709\u2013715","journal-title":"Kidney Int"},{"key":"1337_CR36","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1681\/ASN.2007080902","volume":"19","author":"S Mathew","year":"2008","unstructured":"Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA (2008) Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 19:1509\u20131519","journal-title":"J Am Soc Nephrol"},{"key":"1337_CR37","unstructured":"Mathew S, Strebeck F, Hruska KA (2007) Vascular calcification (VC) protective actions of doxercalciferol in CKD. In: Gendreau MA, Mangili A, Zavod A (eds) Vitamin D therapy in dialysis patients: impact on survival and vascular calcification. Millennium CME Institute, Hampton"},{"key":"1337_CR38","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1172\/JCI105877","volume":"47","author":"E Slatopolsky","year":"1968","unstructured":"Slatopolsky E, Robson AM, Elkan I, Bricker NS (1968) Control of phosphate excretion in uremic man. J Clin Invest 47:1865\u20131874","journal-title":"J Clin Invest"},{"key":"1337_CR39","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","volume":"46","author":"P Kurz","year":"1994","unstructured":"Kurz P, Monier-Faugere M-C, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH (1994) Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46:855\u2013861","journal-title":"Kidney Int"},{"key":"1337_CR40","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.273.9.5253","volume":"273","author":"E Moallem","year":"1998","unstructured":"Moallem E, Kilav R, Silver J, Naveh-Many T (1998) RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J Biol Chem 273:5253\u20135259","journal-title":"J Biol Chem"},{"key":"1337_CR41","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","volume":"96","author":"T Naveh-Many","year":"1995","unstructured":"Naveh-Many T, Rahamimov R, Livni N, Silver J (1995) Parathyroid cell proliferation in normal and chronic renal failure rats. J Clin Invest 96:1786\u20131793","journal-title":"J Clin Invest"},{"key":"1337_CR42","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/01.RES.87.7.e10","volume":"87","author":"S Jono","year":"2000","unstructured":"Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:e10\u2013e17","journal-title":"Circ Res"},{"key":"1337_CR43","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","volume":"98","author":"X Li","year":"2006","unstructured":"Li X, Yang HY, Giachelli CM (2006) Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98:905\u2013912","journal-title":"Circ Res"},{"key":"1337_CR44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","volume":"366","author":"EM Brown","year":"1993","unstructured":"Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC (1993) Cloning and characterization of an extracellular Ca2\u2009+\u2009-sensing receptor from bovine parathyroid. Nature 366:575\u2013580","journal-title":"Nature"},{"key":"1337_CR45","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1681\/ASN.V661530","volume":"6","author":"EM Brown","year":"1995","unstructured":"Brown EM, Hebert SC (1995) A cloned Ca2+ sensing receptor: a mediator of direct effects of extracellular Ca2+ on renal function? J Am Soc Nephrol 6:1530\u20131540","journal-title":"J Am Soc Nephrol"},{"key":"1337_CR46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ki.1996.343","volume":"50","author":"MC Langub Jr","year":"1996","unstructured":"Langub MC Jr, Koszewski NJ, Turner HV, Monier-Faugere MC, Geng Z, Malluche HH (1996) Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy. Kidney Int 50:515\u2013520","journal-title":"Kidney Int"},{"key":"1337_CR47","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1046\/j.1523-1755.61.s80.19.x","volume":"61","author":"P Stenvinkel","year":"2002","unstructured":"Stenvinkel P, Barany P, Heimburger O, Pecoits-Filho R, Lindholm B (2002) Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Kidney Int 61:S103\u2013S108","journal-title":"Kidney Int"},{"key":"1337_CR48","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1523-1755.2004.00512.x","volume":"65","author":"EM Simmons","year":"2004","unstructured":"Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA (2004) Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 65:1357\u20131365","journal-title":"Kidney Int"},{"key":"1337_CR49","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/ndt\/17.9.1684","volume":"17","author":"R Pecoits-Filho","year":"2002","unstructured":"Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P (2002) Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684\u20131688","journal-title":"Nephrol Dial Transplant"},{"key":"1337_CR50","first-page":"221","volume-title":"Renal osteodystrophy","author":"KA Hruska","year":"1998","unstructured":"Hruska KA (1998) Growth factors and cytokines in renal osteodystrophy. In: Bushinsky DA (ed) Renal osteodystrophy. Lippincott-Raven, Philadelphia, pp 221\u2013261"},{"key":"1337_CR51","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/ki.1995.251","volume":"47","author":"DA Bushinsky","year":"1995","unstructured":"Bushinsky DA (1995) The contribution of acidosis to renal osteodystrophy. Kidney Int 47:1816\u20131832","journal-title":"Kidney Int"},{"key":"1337_CR52","first-page":"F442","volume":"262","author":"NS Krieger","year":"1992","unstructured":"Krieger NS, Sessler NE, Bushinsky DA (1992) Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol 262:F442\u2013F448","journal-title":"Am J Physiol"},{"key":"1337_CR53","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","volume":"58","author":"AM Alem","year":"2000","unstructured":"Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C (2000) Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396\u2013399","journal-title":"Kidney Int"},{"key":"1337_CR54","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2003.12.004","volume":"43","author":"J Cunningham","year":"2004","unstructured":"Cunningham J, Sprague S, Cannata-Andia J, Coco M, Cohen-Solal M, Fitzpatrick L, Goltzmann D, Lafage-Proust MH, Leonard M, Ott S, Rodriguez M, Stehman-Breen C, Stern P, Weisinger J (2004) Osteoporosis in chronic kidney disease. Am J Kidney Dis 43:566\u2013571","journal-title":"Am J Kidney Dis"},{"key":"1337_CR55","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.semnephrol.2003.08.013","volume":"24","author":"C Stehman-Breen","year":"2004","unstructured":"Stehman-Breen C (2004) Osteoporosis and chronic kidney disease. Semin Nephrol 24:78\u201381","journal-title":"Semin Nephrol"},{"key":"1337_CR56","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","volume":"56","author":"M Rix","year":"1999","unstructured":"Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K (1999) Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56:1084\u20131093","journal-title":"Kidney Int"},{"key":"1337_CR57","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1073\/pnas.1036475100","volume":"100","author":"M Bonyadi","year":"2003","unstructured":"Bonyadi M, Waldman SD, Liu D, Aubin JE, Grynpas MD, Stanford WL (2003) Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1\/Ly-6A null mice. Proc Natl Acad Sci USA 100:5840\u20135845","journal-title":"Proc Natl Acad Sci USA"},{"key":"1337_CR58","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1525-139X.2001.00057-2.x","volume":"14","author":"C Stehman-Breen","year":"2001","unstructured":"Stehman-Breen C (2001) Bone mineral density measurements in dialysis patients. Semin Dial 14:228\u2013229","journal-title":"Semin Dial"},{"key":"1337_CR59","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0272-6386(99)70430-0","volume":"33","author":"C Stehman-Breen","year":"1999","unstructured":"Stehman-Breen C, Sherrard D, Walker A, Sadler R, Alem A, Lindberg J (1999) Racial differences in bone mineral density and bone loss among end-stage renal disease patients. Am J Kidney Dis 33:941\u2013946","journal-title":"Am J Kidney Dis"},{"key":"1337_CR60","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","volume":"36","author":"M Coco","year":"2000","unstructured":"Coco M, Rush H (2000) Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115\u20131121","journal-title":"Am J Kidney Dis"},{"key":"1337_CR61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1525-139X.2007.00300.x","volume":"20","author":"KA Hruska","year":"2007","unstructured":"Hruska KA, Saab G, Mathew S, Lund R (2007) Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Semin Dial 20:309\u2013315","journal-title":"Semin Dial"},{"key":"1337_CR62","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American society for bone and mineral research. J Bone Miner Res 22:1479\u20131491","journal-title":"J Bone Miner Res"},{"key":"1337_CR63","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","volume":"117","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa S, Imel EA, Kreiter ML, Yu X, Mackenzie DS, Sorenson AH, Goetz R, Mohammadi M, White KE, Econs MJ (2007) A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 117:2684\u20132691","journal-title":"J Clin Invest"},{"key":"1337_CR64","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2004-2302","volume":"90","author":"S Ichikawa","year":"2005","unstructured":"Ichikawa S, Lyles KW, Econs MJ (2005) A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: Evidence that the disorder is autosomal recessive. J Clin Endocrinol Metab 90:2420\u20132423","journal-title":"J Clin Endocrinol Metab"},{"key":"1337_CR65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","volume":"14","author":"A Benet-Pages","year":"2005","unstructured":"Benet-Pages A, Orlik P, Strom TM, Lorenz-Depiereux B (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14:385\u2013390","journal-title":"Hum Mol Genet"},{"key":"1337_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00355.x","volume":"65","author":"SC Schiavi","year":"2004","unstructured":"Schiavi SC, Kumar R (2004) The phosphatonin pathway: New insights in phosphate homeostasis. Kidney Int 65:1\u201314","journal-title":"Kidney Int"},{"key":"1337_CR67","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","volume":"281","author":"H Kurosu","year":"2006","unstructured":"Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M (2006) Regulation of fibroblast growth factor-23 signaling by Klotho. J Biol Chem 281:6120\u20136123","journal-title":"J Biol Chem"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-009-1337-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-009-1337-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-009-1337-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T15:35:13Z","timestamp":1634139313000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-009-1337-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,7]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["1337"],"URL":"https:\/\/doi.org\/10.1007\/s00467-009-1337-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,7]]}}}